Evaluating Dose Timing (Morning vs Evening) of Endocrine-based Therapies in Metastatic Breast and Prostate Cancers
- Status
- RECRUITING
- Phase
- PHASE4
Clinical Trials Related to Metastatic Prostate Cancer
Related studies linked through entity extraction aliases.
Low Dose Naltrexone (LDN) for Management of Fatigue in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Physician- and Patient-based Barriers to NGS Testing
- Status
- RECRUITING
- Phase
- NA
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1
The Effect of a Structured Strength and Endurance Training Program on Quality of Life, Fitness, Blood Parameters and Survival in Prostate Cancer Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
A Study of Tarlatamab for People With Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer
- Status
- RECRUITING
- Phase
- NA
PRostate Cancer Plasma Integrative Multi-modal Evaluation
- Status
- RECRUITING
- Phase
- N/A
Comparison of Different Methods of CAPTure of Circulating Tumour Cells (CTC) in Patients With Metastatic Breast or Prostate Cancer
- Status
- RECRUITING
- Phase
- NA
Clinical Study of Safety and Efficacy of Universal PSMA CAR- T in Refractory CRPC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Prostate Cryoablation Combined With Metronomic Cyclophosphamide for Metastatic Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of Evofosfamide in Combination with Zalifrelimab and Balstilimab
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE2
18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE4
Combination of TURP and Standard Systemic Therapy for MPCa
- Status
- RECRUITING
- Phase
- PHASE2
Trial Targeting Gut Bacterial Androgen Production to Reverse Therapeutic Resistance to Abiraterone in Patients With Metastatic Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Talazoparib Plus Enzalutamide After Progression to Abiraterone in Metastatic Prostate Cancer: (TEAM PC)
- Status
- RECRUITING
- Phase
- PHASE2
A Study of the Absorption, Distribution, Metabolism, and Elimination of Opevesostat (MK-5684) in Healthy Adult Male Participants (MK-5684-008)
- Status
- COMPLETED
- Phase
- PHASE1